- Home
- PASG vs OVID Comparison
PASG vs OVID Comparison
Compare PASG & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PASG
- OVID
- Stock Information
- Founded
- PASG 2017
- OVID 2014
- Country
- PASG United States
- OVID United States
- Employees
- PASG 60
- OVID N/A
- Industry
- PASG Biotechnology: Pharmaceutical Preparations
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- PASG Health Care
- OVID Health Care
- Exchange
- PASG Nasdaq
- OVID Nasdaq
- Market Cap
- PASG 20.3M
- OVID 20.6M
- IPO Year
- PASG 2020
- OVID 2017
- Fundamental
- Price
- PASG $0.41
- OVID $0.33
- Analyst Decision
- PASG Strong Buy
- OVID Strong Buy
- Analyst Count
- PASG 3
- OVID 4
- Target Price
- PASG $7.67
- OVID $3.13
- AVG Volume (30 Days)
- PASG 286.0K
- OVID 1.7M
- Earning Date
- PASG 08-07-2025
- OVID 08-12-2025
- Dividend Yield
- PASG N/A
- OVID N/A
- EPS Growth
- PASG N/A
- OVID N/A
- EPS
- PASG N/A
- OVID N/A
- Revenue
- PASG N/A
- OVID $548,000.00
- Revenue This Year
- PASG N/A
- OVID N/A
- Revenue Next Year
- PASG N/A
- OVID $5.32
- P/E Ratio
- PASG N/A
- OVID N/A
- Revenue Growth
- PASG N/A
- OVID 15.61
- 52 Week Low
- PASG $0.26
- OVID $0.24
- 52 Week High
- PASG $1.33
- OVID $1.47
- Technical
- Relative Strength Index (RSI)
- PASG 53.70
- OVID 55.08
- Support Level
- PASG $0.32
- OVID $0.30
- Resistance Level
- PASG $0.42
- OVID $0.33
- Average True Range (ATR)
- PASG 0.04
- OVID 0.03
- MACD
- PASG -0.00
- OVID 0.00
- Stochastic Oscillator
- PASG 61.64
- OVID 75.00
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.